Navigation Links
Mylan One of First to Launch Generic Version of Boniva®
Date:3/20/2012

PITTSBURGH, March 20, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Ibandronate Sodium Tablets, 150mg. This product is the generic version of Roche's Boniva®, which is indicated for the treatment and prevention of osteoporosis in postmenopausal women.

Boniva® had U.S. sales of approximately $517 million for the 12 months ending Dec. 31, 2011, according to IMS Health. Mylan is shipping the product immediately.

Currently, Mylan has 173 ANDAs pending FDA approval representing $100.9 billion in annual sales, according to IMS Health. Forty-two of these pending ANDAs are potential first-to-file opportunities, representing $27.4 billion in annual brand sales, for the 12 months ending December 31, 2011, according to IMS Health.

Mylan Inc. ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 150 countries and territories. The company maintains one of the industry's broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world's largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies. For more information about Mylan, please visit www.mylan.com. For more information about generic drugs, please visit www.ChoosingGenerics.com.


'/>"/>
SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Mylan Canada Receives Health Canada Approval for Generic Version of Crestor®
2. Mylan Continues to Pursue Damages and Injunction Against Sunovions Brovana® in Ongoing Litigation
3. Mylan Pharmaceuticals President Tony Mauro Elected Chairman of GPhA
4. Mylan Secures an Additional $300 Million of Committed Financing
5. Mylan Reports Adjusted Diluted EPS of $0.53 for the Quarter, an 18% Increase Over Prior Year Quarter; and $2.04 for the Year, a 27% Increase Over Prior Year
6. Mylan and Pfizer Announce Epinephrine Auto-injector Settlement Agreement
7. Mylan to Change Name of Specialty Subsidiary From Dey Pharma to Mylan Specialty
8. Mylan Actively Addressing Shortage of Preservative-Free Methotrexate Injection
9. Mylan CEO Heather Bresch Testifies Before Congress in Support of Generic Drug User Fee Program and Urges Update of Federal Food, Drug and Cosmetic Act of 1938 to Create a Level Playing Field for Manufacturers
10. Mylan Completes Acquisition of Two Limited-Competition Dermatological Products from Valeant
11. Valeant Pharmaceuticals Completes Divestiture of Generic Dermatology Products to Mylan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... N.Y. and PARIS , ... REGN)  and Sanofi have entered into a new ... cancer treatments in the emerging field of immuno-oncology. As ... develop a programmed cell death protein 1 (PD-1) inhibitor ... clinical trials in 2016 with new therapeutic candidates based ...
(Date:7/27/2015)... ATLANTA , July 27, 2015  SeraCare ... vitro diagnostics manufacturers, announced at the 2015 AACC ... strategic partnership agreement with ViveBio, LLC, a biotechnology ... based upon ViveST™ technology.  Products enabled with ViveST™ ... dried, shelf stable format.  Under the terms of ...
(Date:7/27/2015)... July 27, 2015  Array BioPharma Inc. ... for the fourth quarter and full year ... call to discuss those results on Monday, ... Officer will lead the call. ... 464-3927Toll:(765) 507-2598Pass Code: 68380312 Webcast, including Replay ...
Breaking Medicine Technology:Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 2Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 3Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 4Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 5Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 6Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 7Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 8SeraCare Life Sciences Announces Strategic Partnership with ViveBio to Enable Next Generation Preanalytic Products for the IVD Industry 2SeraCare Life Sciences Announces Strategic Partnership with ViveBio to Enable Next Generation Preanalytic Products for the IVD Industry 3
... BMRN ) will host a Research and Development ... from 8:00 a.m. to 12:00 p.m. at the St. Regis ... and outside experts will provide an update on the company,s ... Interested parties may access a live audio webcast ...
... N.J. , Oct. 5 Health Strategies ... pharmaceutical and biotechnology professionals, has launched a new ... provide essential insights into the complex institutional market, ... care facilities. Offering one-stop convenience, the services give ...
Cached Medicine Technology:BioMarin to Host a Research and Development Day on October 19th 2Health Strategies Group Introduces New One-Stop Suite of Intelligence Services for Optimizing Marketing and Sales Resources in the Institutional Channel 2Health Strategies Group Introduces New One-Stop Suite of Intelligence Services for Optimizing Marketing and Sales Resources in the Institutional Channel 3
(Date:7/28/2015)... ... 28, 2015 , ... Peter Forbes, President of the Veterans Fund of the United States, managing ... the Veterans Coalition, is spearheading a campaign to help homeless Veterans by giving them “A ... and trade skills. Forbes and the UVBH assists and supports Vets through the Veterans ...
(Date:7/27/2015)... ... July 28, 2015 , ... Conducting Advanced ... Techniques to Improve the Quality of Investigations , **Presented by FDAnews and Learning ... and CAPAs have been the #1 reason for 483 observations since 1997! , ...
(Date:7/27/2015)... ... July 28, 2015 , ... The National Association of Professional Women (NAPW) ... Woman of the Year Circle. She is recognized with this prestigious distinction for leadership ... is the nation’s leading networking organization exclusively for professional women. , “I’m pleased to ...
(Date:7/27/2015)... MA (PRWEB) , ... July 27, 2015 , ... ... has transformed the science of the little-known and incurable disease, facioscapulohumeral muscular dystrophy ... the American Academy of Neurology (AAN). The FSHD care guideline is published today. ...
(Date:7/27/2015)... ... July 27, 2015 , ... North Central Surgical Center Hospital will be holding ... all those prospective joint-replacement patients, along with their friends and family members, to attend. ... classes (Aug 6, Sept 8 [Tue due to Labor Day], Oct 5, Nov 2, ...
Breaking Medicine News(10 mins):Health News:Veterans Fund of the United States Launches “Adopt A Homeless Veteran” Campaign 2Health News:Veterans Fund of the United States Launches “Adopt A Homeless Veteran” Campaign 3Health News:FDAnews Announces: Conducting Advanced Root Cause Analysis CAPA Investigations, Sept. 16-17, 2015, Raleigh, NC 2Health News:FDAnews Announces: Conducting Advanced Root Cause Analysis CAPA Investigations, Sept. 16-17, 2015, Raleigh, NC 3Health News:FDAnews Announces: Conducting Advanced Root Cause Analysis CAPA Investigations, Sept. 16-17, 2015, Raleigh, NC 4Health News:NAPW Inducts Jane Simmons, Counseling Intern at Omar Bradley Middle School of the Northeast Independent School District , Into its VIP Woman of the Year Circle 2Health News:First-Ever FSHD Evidence-based Care Guideline Published by the American Academy of Neurology 2Health News:North Central Surgical Center Hospital to Hold Joint Wellness Classes 2
... , ... Reportlinker.com announces that a new market research report is ... , http://www.reportlinker.com/p0171106/Diet-Foods--2010-Edition.html , The diet foods market ... sectors. These have followed different growth paths. The old established ...
... American College of Physicians (ACP) has issued a ... physicians, and caregivers. The Journal of ... Patients and Physicians: Ethical Guidance to Optimize Relationships." ... to help physicians manage relationships with patients and ...
... fast-acting compound that appears to improve cognitive function impairments ... progressive Alzheimer,s disease has been identified by scientists at ... University Medical Center Program in Drug Discovery. Researchers hope ... The compound benzylquinolone carboxylic acid (BQCA) has ...
... , MOUNTAIN ... Inc. (Nasdaq: OMCL ), a leading provider of ... NewYork-Presbyterian Hospital has chosen Omnicell as its primary vendor ... safety of medications for our patients, we need a system that ...
... significantly, study finds , TUESDAY, Jan. 12 (HealthDay News) -- ... heart rate boosts the risk of dying from a heart ... Norwegian researchers tracked the health of about 50,000 healthy adults, ... During that time, 6,033 men and 4,442 women died. Heart ...
... ... announcing a new meal plan catering to vegetarian dieters. , ... (PRWEB) January 12, 2010 -- Diet-to-Go, a ... line of meals that can help millions of health-conscious Americans eat great, lose weight, ...
Cached Medicine News:Health News:Reportlinker Adds Diet Foods- 2010 Edition 2Health News:Reportlinker Adds Diet Foods- 2010 Edition 3Health News:Reportlinker Adds Diet Foods- 2010 Edition 4Health News:Reportlinker Adds Diet Foods- 2010 Edition 5Health News:Reportlinker Adds Diet Foods- 2010 Edition 6Health News:Reportlinker Adds Diet Foods- 2010 Edition 7Health News:Reportlinker Adds Diet Foods- 2010 Edition 8Health News:Reportlinker Adds Diet Foods- 2010 Edition 9Health News:Reportlinker Adds Diet Foods- 2010 Edition 10Health News:Reportlinker Adds Diet Foods- 2010 Edition 11Health News:Reportlinker Adds Diet Foods- 2010 Edition 12Health News:Reportlinker Adds Diet Foods- 2010 Edition 13Health News:Reportlinker Adds Diet Foods- 2010 Edition 14Health News:New ethical guidance from ACP for patient-physician-caregiver relationship 2Health News:New compound improves cognitive decline, symptoms of Alzheimer's disease in rodents 2Health News:New compound improves cognitive decline, symptoms of Alzheimer's disease in rodents 3Health News:NewYork-Presbyterian Hospital Selects Omnicell for Medication Management 2Health News:NewYork-Presbyterian Hospital Selects Omnicell for Medication Management 3Health News:NewYork-Presbyterian Hospital Selects Omnicell for Medication Management 4Health News:Faster Heart Rate May Raise Risk of Heart Attack Death 2Health News:Diet-to-Go Delivers Deliciously Healthy Vegetarian Meals 2
The Oculus easyfield is an exciting new compact perimeter to do automatic static perimetry up to 30 degrees eccentricity. It has been designed for the combined use as a visual field screener and peri...
... has additional hardware and software features to ... demanding clinics or teaching institutions. Standard with ... parameters for experimental or clinical studies. Ethernet ... for further tests including Flicker- and Color ...
... Designed around the patented ... Octopus 301 sets the trend ... decade. Ideal for routine screening ... performance, accuracy and quality ...
... FDT is a breakthrough in visual field testing ... in pre-test. Introducing FDT, the first visual field ... enough to be used even in pre-test. Affordably ... trials behind it to validate performance. The instrument ...
Medicine Products: